On 2023-11-20, Baudax Bio, Inc. (BXRXQ) announced earnings per share of $-0.29 for the fiscal quarter ending 2023-09-30, beating the average analyst estimate of $-0.53.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2023-11-20 | 2023-09-30 | $-0.53 | $-0.29 |
| 2023-08-16 | 2023-06-30 | $-2.04 | $-1.49 |
| 2023-05-12 | 2023-03-31 | $5.75 | $-3.19 |
| 2023-02-23 | 2022-12-31 | -- | $-12.33 |
| 2022-11-08 | 2022-09-30 | $-21.20 | $-98.80 |
| 2022-08-11 | 2022-06-30 | $-50.80 | $-42.00 |
| 2022-05-04 | 2022-03-31 | $-74.00 | $-126.80 |
| 2022-03-16 | 2021-12-31 | -- | $401.60 |
| 2021-11-04 | 2021-09-30 | $-223.78 | $-279.72 |
| 2021-08-05 | 2021-06-30 | $-307.69 | $-293.71 |
| 2021-05-05 | 2021-03-31 | $-265.73 | $-265.73 |
| 2020-11-09 | 2020-09-30 | $-1174.83 | $-1006.99 |
| 2020-08-10 | 2020-06-30 | $-1034.96 | $-1034.96 |
| 2020-05-08 | 2020-03-31 | $-1272.73 | $-1160.84 |